IPRIPR2023-00532Final Written Decision
Celltrion, Inc. et al.v.Regeneron Pharmaceuticals, Inc.
IPR challenge of US 10130681.
Type
IPR
Filed
Feb 10, 2023
Instituted
Mar 22, 2023
Decided
Aug 23, 2024
Patent
Application
15471506
Inventor
George D. YANCOPOULOS
Granted
Nov 20, 2018
01
Timeline
3 milestones
2023-02-10Petition filed
2023-03-22Institution
2024-01-09Terminated
02
Parties & counsel
Petitioner
Celltrion, Inc. et al.
Counsel
Green, Loraet al
Patent Owner
Regeneron Pharmaceuticals, Inc.
Counsel
Fishman, Deborahet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →